Skip to main content
Premium Trial:

Request an Annual Quote

Sciex Inks Comarketing Agreement With EluciData for Metabolomics Data Processing

NEW YORK (GenomeWeb) – Sciex today announced a comarketing agreement with EluciData, a provider of tools for metabolomics data processing.

Under the terms of the agreement, Sciex will promote EluciData's Polly multi-omics platform in conjunction with its TripleTOF, X500R QTOF, and QTRAP instruments and its Differential Ion Mobility technologies.

Financial terms of the deal were not disclosed.

"Improving the efficiency of metabolomics workflows is critical if academic researchers and pharma customers want to advance precision medicine," Mark Cafazzo, Sciex director of strategic market management, said in a statement. "The use of Polly with Sciex metabolomics workflows accelerates their capabilities and empowers them to spend more time on the biology than on crunching data through fragmented software tools."

Polly is a cloud-based end-to-end platform that standardizes and streamlines metabolomics data analysis workflows and integrates other forms of omics data.

The agreement follows other deals EluciData has made for its platform. In December 2018, for example, the firm signed a four-year contract with Auron Therapeutics to provide data analytics.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.